1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(CIS-3-HYDROXYCYCLOHEXYL)-UREA
Compound with spectra: 1 NMR
![1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(CIS-3-HYDROXYCYCLOHEXYL)-UREA](/api/compound/AWxGENUffrK.png?ph=true&h=300&w=458 "1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(CIS-3-HYDROXYCYCLOHEXYL)-UREA")
| SpectraBase Compound ID | AWxGENUffrK |
|---|---|
| InChI | InChI=1S/C23H28ClN3O6S/c1-33-21-10-7-16(24)13-20(21)22(29)25-12-11-15-5-8-19(9-6-15)34(31,32)27-23(30)26-17-3-2-4-18(28)14-17/h5-10,13,17-18,28H,2-4,11-12,14H2,1H3,(H,25,29)(H2,26,27,30)/t17-,18+/m1/s1 |
| InChIKey | VFBAJFAMXTVSQA-MSOLQXFVSA-N |
| Mol Weight | 510.01 g/mol |
| Molecular Formula | C23H28ClN3O6S |
| Exact Mass | 509.138735 g/mol |
| Enantiomer InChIKey | VFBAJFAMXTVSQA-ZWKOTPCHSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
5-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]-2-methoxybenzenesulfonyl chloride
1-{2-[2,5-BIS(2,2,2-TRIFLUOROETHOXY)BENZAMIDO]ETHYL}-3-(p-TOLYL-SULFONYL)UREA
1H-pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-
Glimepiride
ethyl {2-[(5-chloro-2-methoxybenzoyl)amino]-1,3-thiazol-4-yl}acetate
5-chloro-2-methoxy-N-(4-methyl-3-nitrophenyl)benzamide
5-chloro-N-(2,4-dimethoxyphenyl)-2-methoxybenzamide
5-chloro-N-(2,3-dihydro-1H-inden-5-yl)-2-methoxybenzamide
N-(1-benzyl-1H-pyrazol-3-yl)-5-chloro-2-methoxybenzamide
| Title | Journal or Book | Year |
|---|---|---|
| Hydroxyl-Substituted sulfonylureas as potent inhibitors of specific [3H]Glyburide binding to rat brain synaptosomes | Bioorganic & Medicinal Chemistry | 2003 |